What is the CVSS score of CVE-2023-6517?

CVE-2023-6517 has a CVSS 3.1 base score of 7.5 (High). CVSS vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N. EPSS exploitation probability: 0.1%.

Mia Med CVE-2023-6517

HIGH

Exposure of Sensitive Information Due to Incompatible Policies (CWE-213)

2024-02-08 iletisim@usom.gov.tr

Information Disclosure Mia Med

7.5

CVSS 3.1 · NVD

Severity by source

NVD PRIMARY

7.5 HIGH

AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

Primary rating from NVD · only source for this CVE.

CVSS VectorNVD

CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:N/A:N

Attack Vector

Network

Attack Complexity

Low

Privileges Required

None

User Interaction

None

Scope

Unchanged

Confidentiality

High

Integrity

None

Availability

None

Lifecycle Timeline

CVE Published

Feb 08, 2024 - 12:15 cve.org

HIGH 7.5

DescriptionCVE.org

Exposure of Sensitive Information Due to Incompatible Policies vulnerability in Mia Technology Inc. MİA-MED allows Collect Data as Provided by Users.

This issue affects MİA-MED: before 1.0.7.

AnalysisAI

Exposure of Sensitive Information Due to Incompatible Policies vulnerability in Mia Technology Inc. Rated high severity (CVSS 7.5), this vulnerability is remotely exploitable, no authentication required, low attack complexity. No vendor patch available.

Technical ContextAI

This vulnerability is classified under CWE-213. Exposure of Sensitive Information Due to Incompatible Policies vulnerability in Mia Technology Inc. MİA-MED allows Collect Data as Provided by Users.0.7. Affected products include: Miateknoloji Mia-Med. Version information: before 1.0.7..

RemediationAI

No vendor patch is available at time of analysis. Monitor vendor advisories for updates. Apply vendor patches when available. Implement network segmentation and monitoring as interim mitigations.